Delayed Onset of Alopecia Areata in a Patient on Ocrelizumab for Multiple Sclerosis: A Case Report
January 2025
in “
International Journal of Medicine in Developing Countries
”

TLDR Ocrelizumab may cause delayed hair loss in some patients.
This case report discusses a patient with multiple sclerosis who developed alopecia areata after being treated with ocrelizumab. The onset of alopecia areata was delayed, suggesting a potential link between the medication and the condition. The report highlights the importance of monitoring patients on ocrelizumab for unexpected side effects, such as hair loss, even if they occur after a significant delay. This case adds to the understanding of the side effect profile of ocrelizumab and underscores the need for awareness among healthcare providers.